Abstract:Machine learning methods offer time- and cost-effective means for identifying novel chemical matter as well as guiding experimental efforts to map enormous compound-kinase interaction spaces. However, considerable challenges for compound-kinase interaction modeling arise from the heterogeneity of available bioactivity readouts, including single-dose compound profiling results, such as percentage inhibition, and multi-dose-response results, such as IC . Standard activity prediction approaches utilize only dose-response data in the model training, disregarding a substantial portion of available information contained in single-dose measurements. Here, we propose a novel machine learning methodology for compound-kinase activity prediction that leverages both single-dose and dose-response data. Our two-stage model first learns a mapping between single-dose and dose-response bioactivity readouts, and then generates proxy dose-response activity labels for compounds that have only been tested in single-dose assays. The predictions from the first-stage model are then integrated with experimentally measured dose-response activities to model compound-kinase binding based on chemical structures and kinase features. We demonstrate that our two-stage approach yields accurate activity predictions and significantly improves model performance compared to training solely on dose-response labels, particularly in the most practical and challenging scenarios of predicting activities for new compounds and new compound scaffolds. This superior performance is consistent across five evaluated machine learning methods, including traditional models such as random forest and kernel learning, as well as deep learning-based approaches. Using the best performing model, we carried out extensive experimental profiling on a total of 347 selected compound-kinase pairs, achieving a high hit rate of 40% and a negative predictive value of 78%. We show that these rates can be improved further by incorporating model uncertainty estimates into the compound selection process. By integrating multiple activity data types, we demonstrate that our approach holds promise for facilitating the development of training activity datasets in a more efficient and cost-effective way.

Integrating Molecular Dynamics and Machine Learning Algorithms to Predict the Functional Profile of Kinase Ligands

A Hybrid Structure-Based Machine Learning Approach for Predicting Kinase Inhibition by Small Molecules

Leveraging Machine Learning and AlphaFold2 Steering to Discover State-Specific Inhibitors Across the Kinome

Integrated Molecular Modeling and Machine Learning for Drug Design

Leveraging multiple data types for improved compound-kinase bioactivity prediction

Docking-informed machine learning for kinome wide affinity prediction

Predicting binding events in very flexible, allosteric, multi-domain proteins

Dynamics of Post-Translational Modification Inspires Drug Design in the Kinase Family

Machine learning approaches in predicting allosteric sites

Large-scale Prediction of Human Kinase-Inhibitor Interactions Using Protein Sequences and Molecular Topological Structures.

Lessons learned during the journey of data: from experiment to model for predicting kinase affinity, selectivity, polypharmacology, and resistance

Prediction of Threonine-Tyrosine Kinase Receptor-Ligand Unbinding Kinetics with Multiscale Milestoning and Metadynamics

A comprehensive exploration of the druggable conformational space of protein kinases using AI-predicted structures

Classifying protein kinase conformations with machine learning

Can molecular dynamics simulations improve predictions of protein-ligand binding affinity with machine learning?

Perspectives on Ligand/Protein Binding Kinetics Simulations: Force Fields, Machine Learning, Sampling, and User-Friendliness

Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure

Allo-targeting of the kinase domain: Insights from in silico studies and comparison with experiments

Synergistic Application of Molecular Docking and Machine Learning for Improved Binding Pose

MinKLIFSAI: a simple machine learning approach toward selective kinase inhibitor